Thiamine Mononitrate Oral Solution
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
DOWNLOAD PDF HERE
1 DEFINITION
Thiamine Mononitrate Oral Solution contains NLT 95.0% and NMT 115.0% of the labeled amount of thiamine mononitrate (C12H17N5O4S).
2 IDENTIFICATION
A.
Sample solution: Dilute a portion of Oral Solution with water to a concentration of 10 mg/mL of thiamine mononitrate.
Analysis: To 0.5 mL of the Sample solution add 5 mL of 0.5 N sodium hydroxide, then add 0.5 mL of potassium ferricyanide TS and 5 mL of isobutyl alcohol. Shake the mixture vigorously for 2 min, and allow the liquid layers to separate. Illuminate from above by a vertical beam of UV light and observe the air–liquid meniscus at a right angle to this beam.
Acceptance criteria: The air–liquid meniscus shows a vivid blue fluorescence, which disappears when the mixture is slightly acidified, but reappears when it is again made alkaline.
B.
Sample: 5 mL of Oral Solution
Analysis: Add 2 mL of sulfuric acid to the Sample, cool, and superimpose 2 mL of ferrous sulfate TS.
Acceptance criteria: A brown ring is produced at the junction of the two liquids.
3 ASSAY
Procedure
Mobile phase: Methanol and 0.04 M aqueous monobasic potassium phosphate (45:55)
Internal standard solution: 100 μg/mL of methylparaben in Mobile phase
Standard stock solution: 500 μg/mL of USP Thiamine Hydrochloride RS in Mobile phase
Standard solution: Dilute a mixture of equal volumes of the Standard stock solution and Internal standard solution with Mobile phase to obtain a concentration of USP Thiamine Hydrochloride RS of 50 μg/mL.
Sample stock solution: Equivalent to 500 μg/mL of thiamine mononitrate in Mobile phase from an accurately measured volume of Oral
Solution
Sample solution: Dilute a mixture of equal volumes of the Sample stock solution and Internal standard solution with Mobile phase to obtain a concentration of thiamine mononitrate of 50 μg/mL.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 254 nm
Column: 3.9-mm × 30-cm; packing L1
Flow rate: 1 mL/min
Injection size: 25 μL
System suitability
Sample: Standard solution
[Note—The relative retention times for thiamine and methylparaben are about 0.35 and 1.0, respectively.]
Suitability requirements
Resolution: NLT 6.0 between the thiamine and methylparaben
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of thiamine mononitrate in the portion of Oral Solution taken:
Result = (RU/RS) × (CS/CU) × (Mr1/Mr2) × 100
RU = peak area ratio of thiamine to methylparaben from the Sample solution
RS = peak area ratio of thiamine to methylparaben from the Standard solution
CS = concentration of USP Thiamine Hydrochloride RS in the Standard stock solution (μg/mL)
CU = nominal concentration of thiamine mononitrate in the Sample stock solution (μg/mL)
Mr1 = molecular weight of thiamine mononitrate, 327.36
Mr2 = molecular weight of thiamine hydrochloride, 337.27
Acceptance criteria: 95.0%–115.0%
4 OTHER COMPONENTS
Alcohol Determination, Method II 〈611〉: 90.0%–110.0% of the labeled quantity of C H OH, using acetone as the internal standard
5 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in tight, light-resistant containers.
USP Reference Standards 〈11〉
USP Thiamine Hydrochloride RS

